alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 113th Congress]
[From the U.S. Government Publishing Office]
[S. 1322 Introduced in Senate (IS)]

113th CONGRESS
  1st Session
                                S. 1322

To amend the Controlled Substances Act relating to controlled substance 
                               analogues.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             July 18, 2013

Ms. Klobuchar (for herself, Mr. Graham, and Mrs. Feinstein) introduced 
the following bill; which was read twice and referred to the Committee 
                            on the Judiciary

_______________________________________________________________________

                                 A BILL

 
To amend the Controlled Substances Act relating to controlled substance 
                               analogues.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Synthetic Abuse and Labeling of 
Toxic Substances Act of 2013'' or the ``SALTS Act''.

SEC. 2. CONTROLLED SUBSTANCE ANALOGUES.

    Section 203 of the Controlled Substances Act (21 U.S.C. 813) is 
amended--
            (1) by striking ``A controlled'' and inserting ``(a) In 
        General.--A controlled''; and
            (2) by adding at the end the following:
    ``(b) Determination.--In determining whether a controlled substance 
analogue was intended for human consumption under subsection (a), the 
following factors may be considered, along with any other relevant 
factors:
            ``(1) The marketing, advertising, and labeling of the 
        substance.
            ``(2) The known efficacy or usefulness of the substance for 
        the marketed, advertised or labeled purpose.
            ``(3) The difference between the price at which the 
        substance is sold and the price at which the substance it is 
        purported to be or advertised as is normally sold.
            ``(4) The diversion of the substance from legitimate 
        channels and the clandestine importation, manufacture, or 
        distribution of the substance.
            ``(5) Whether the defendant knew or should have known the 
        substance was intended to be consumed by injection, inhalation, 
        ingestion, or any other immediate means.
    ``(c) Limitation.--For purposes of this section, evidence that a 
substance was not marketed, advertised, or labeled for human 
consumption, by itself, shall not be sufficient to establish that the 
substance was not intended for human consumption.''.
                                 <all>
```
<PAGE>   1
 
                                                                    EXHIBIT 11.1
 
                            COMPUTRON SOFTWARE, INC.
 
            STATEMENT RE: COMPUTATION OF NET INCOME (LOSS) PER SHARE
                     (IN THOUSANDS, EXCEPT PER SHARE DATA)
                                  (UNAUDITED)
 
<TABLE>
<CAPTION>
                                                           THREE MONTHS
                                                               ENDED           NINE MONTHS ENDED
                                                           SEPTEMBER 30,         SEPTEMBER 30,
                                                         -----------------     ------------------
                                                          1994       1995       1994        1995
                                                         ------     ------     -------     ------
<S>                                                      <C>        <C>        <C>         <C>
Net income (loss)......................................  $ (743)    $  426     $(5,120)    $2,406
                                                         ======     ======      ======     ======
Weighted average common and common equivalent shares
  outstanding:
  Shares outstanding at the beginning of the period....  17,828     17,829      15,551     17,829
  Weighted average shares issued during the period.....      --      1,006       1,183        339
  Weighted average common stock equivalents............     742      1,016         583        956
  Weighted average treasury shares acquired using the
     treasury stock method.............................    (595)      (166)       (583)      (166)
                                                         ------     ------      ------     ------
Weighted average common and common equivalent shares
  outstanding:.........................................  17,975     19,685      16,734     18,958
                                                         ======     ======      ======     ======
Pro forma net income (loss) per share..................  $(0.04)    $ 0.02     $ (0.31)    $ 0.13
                                                         ======     ======      ======     ======
</TABLE>
 
---------------
 
     All share information contained in the per share calculations has been
adjusted to reflect the conversion of all series of Redeemable Convertible
Preferred Stock and Class A and Class B Common Stock into Common Stock as of the
original issuance dates. These equities were converted into Common Stock upon
the closing of the initial public offering on August 29, 1995.
 
                                       19
**Exhibit  13.1**

----

 

**CERTIFICATION  PURSUANT TO****18 U.S.C. SECTION  1350,****AS ADOPTED  PURSUANT TO****SECTION 906  OF THE SARBANES-OXLEY ACT OF 2002**

The undersigned  hereby certify that to the best of our knowledge: 

|  |  | 1. | this annual report      on Form 20-F of BT Group plc fully complies with the requirements of Section      13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|--|--|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  |  |   |                                                                                                                                                                    |
|--|--|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  |  | 2.     | the information contained      in this annual report fairly presents, in all material respects, the financial      condition and results of operations of BT Group plc. |

 

| Date: May 14, 2008 |   | /s/ Ben      Verwaayen                                |
|--------------------|--------|-------------------------------------------------------|
|               |   |                                                       |
|               |   | Name: Bernardus Verwaayen      Title: Chief Executive |
|               |   |                                                  |
|               |   |                                                  |
| Date: May 14, 2008 |   | /s/ Hanif Lalani        |
|               |   |                                                       |
|               |   | Name: Hanif Lalani      Title: Group Finance Director |

 

----
Exhibit 4.18

---





Carl Symon
  3 Pineridge Close
  Beechwood Avenue
  Weybridge
  Surrey
  KT13 9EA

25 July 2006

Dear Carl,

At its meeting on 25 July 2006 the BT Group plc
    Board agreed to increase your fees as Chairman of the Equality of Access
    Board to £70,000 a year, with effect from 1 July 2006

Your total fees as a non-executive director of
    BT Group plc are therefore increased from 1 July 2006 to £120,000 a
    year.

Yours sincerely

/s/ Larry Stone

L W STONE







|Larry StoneCompany SecretaryBT GroupBT
      Centre81 Newgate StreetLondon EC1A 7AJUnited Kingdom | tel
      faxmob email | +44 (0)20 7356 5237+44
      (0)20 7356 6135+44 (0)7740 136290larry.stone@bt.com | BT Group
      plcRegistered Office:81 Newgate Street, London EC1A
      7AJRegistered in England and Wales no.
      4190816www.bt.com
|------------------------------------------------------------------------------------------------- | ---------------------- | -------------------------------------------------------------------------------- | ---------------------------------------------------------------------------------------------------------------------------------------

---
<TABLE> <S> <C>

<ARTICLE>          5
       
<S>                          <C>                   <C>
<PERIOD-TYPE>                      3-MOS                 9-MOS
<FISCAL-YEAR-END>            DEC-31-1996           DEC-31-1996
<PERIOD-START>               JUL-01-1996           JAN-01-1996
<PERIOD-END>                 SEP-30-1996           SEP-30-1996
<CASH>                           7642238               7642238
<SECURITIES>                           0                     0
<RECEIVABLES>                   10009702              10009702
<ALLOWANCES>                      132948                132948
<INVENTORY>                      3695237               3695237
<CURRENT-ASSETS>                22374919              22374919
<PP&E>                          17282680              17282680
<DEPRECIATION>                   5243632               5243632
<TOTAL-ASSETS>                  35295724              35295724
<CURRENT-LIABILITIES>            6925177               6925177
<BONDS>                            17887                 17887
<PREFERRED-MANDATORY>                  0                     0
<PREFERRED>                            0                     0
<COMMON>                        16037270              16037270
<OTHER-SE>                      11704785              11704785
<TOTAL-LIABILITY-AND-EQUITY>    35295724              35295724
<SALES>                          8097196              24384835
<TOTAL-REVENUES>                11234190              33174875
<CGS>                            2012988               6343710
<TOTAL-COSTS>                    4601248              13411479
<OTHER-EXPENSES>                       0                     0
<LOSS-PROVISION>                  (19770)                39160
<INTEREST-EXPENSE>                   579                  1945
<INCOME-PRETAX>                  1850838               4119579
<INCOME-TAX>                      666302               1483050
<INCOME-CONTINUING>              1184536               2636529
<DISCONTINUED>                         0                     0
<EXTRAORDINARY>                        0                     0
<CHANGES>                              0                     0
<NET-INCOME>                     1184536               2636529
<EPS-PRIMARY>                        .24                   .52
<EPS-DILUTED>                        .24                   .52
<PAGE>

                                                                    EXHIBIT 23.2

CONSENT OF PRICEWATERHOUSECOOPERS LLP, INDEPENDENT ACCOUNTANTS

                       CONSENT OF INDEPENDENT ACCOUNTANTS

We hereby consent to the incorporation by reference in the Registration
Statements of Rare Medium Group, Inc. (formerly ICC Technologies, Inc.) (the
Company) on Form S-8 (File Nos. 33-37036, 33-37037, 33-85634, 33-85636,
33-89122, 33-89124 and 333-76957) and Registration Statements on Form S-3 (File
Nos. 33-76107, 333-95829 and 333-30170) of our report, dated March 20, 1998,
relating to the consolidated financial statements of the Company which appears
in the Company's Annual Report on Form 10-K for the year ended December 31,
1999. We also consent to the incorporation by reference in these registration
statements of our report, dated March 20, 1998, relating to the financial
statements of Engelhard/ICC, which also appears in such Annual Report on Form
10-K for the year ended December 31, 1999.

/s/ PricewaterhouseCoopers LLP
Philadelphia, Pennsylvania
February 22, 2000.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from Consolidated
Captial Properties VI 1995 Year-End 10-KSB and is qualified in its entirety by
reference to such 10-KSB filing.
</LEGEND>
<CIK> 0000755908
<NAME> CONSOLIDATED CAPITAL PROPERTIS VI
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1995
<PERIOD-END>                               DEC-31-1995
<CASH>                                           1,311
<SECURITIES>                                       390
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0<F1>
<PP&E>                                          16,306
<DEPRECIATION>                                   6,452
<TOTAL-ASSETS>                                  12,302
<CURRENT-LIABILITIES>                                0<F1>
<BONDS>                                         10,314
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                       1,503
<TOTAL-LIABILITY-AND-EQUITY>                    12,302
<SALES>                                              0
<TOTAL-REVENUES>                                 3,289
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                 4,039
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 874
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (750)
<EPS-PRIMARY>                                   (4.13)
<EPS-DILUTED>                                        0
<FN>
<F1>The Partnership has an unclassified balance sheet.
</FN>
        

</TABLE>
# lnventoryExpertService
·- A division of the American Chemical Society Phone: 800-631-1884,614-447-3870 Fax: 614-447-3747 E-mail; answers@cas.org Web : www. cas.org/prod ucts/other-cas- prod ucts/c lien 1-so rv icos/ 

# INVENTORY EXPERT SERVICE REPORT IES Order Number: 385222 Registry Number: 22239-24-3 CA Index Name: Phosphoric acid, sodium titanium(4+) salt (3:1:2)

Please print the above CA Index Name on the appropriate page of your PMN.
CAS 

# D If this box is checked, CAS has made correction(s) marked in red to your IES order. Please make the same corrections to your PMN before submitting it to the EPA. 2540 Olentangy River Road P.O. Box 3343 Columbus, OH 43210-0334 USA
<PAGE>


                                   EXHIBIT 23

                         INDEPENDENT AUDITORS' CONSENT

The Board of Directors of Newhall Management Corporation and Partners of The
  Newhall Land and Farming Company:

We consent to incorporation by reference in the Registration Statements on 
Form S-8 (Numbers 033-53767, 033-53769, 033-58171 and 333-15303) of The 
Newhall Land and Farming Company of our report dated January 20, 1999, 
relating to the consolidated balance sheets of The Newhall Land and Farming 
Company and subsidiaries as of December 31, 1998 and 1997, and the related 
consolidated statements of income, changes in partners' capital, and cash 
flows for each of the years in the three-year period ended December 31, 1998, 
which report appears in the December 31, 1998, annual report on Form 10-K of 
The Newhall Land and Farming Company.

                                                     /S/ KPMG LLP

Los Angeles, California
March 23, 1999
EXHIBIT
32.1


CERTIFICATION
PURSUANT TO 18 USC, SECTION 1350,


AS
ADOPTED PURSUANT TO SECTION 906


OF
THE SARBANES-OXLEY ACT OF 2002








In connection with the Annual Report of
NeoTactix Corporation (the “Company”) on Form 10-K for the year ended December
31, 2007, as filed with the Securities and Exchange Commission on or about the
date hereof (the “Report”), I, Scott W. Absher, President of the Company,
certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the
Sarbanes-Oxley Act of 2002, that:





(1)           The
Report fully complies with the requirements of Sections 13(a) or 15(d) of the
Securities Exchange Act of 1934; and





(2)           Information
contained in the Report fairly presents, in all material respects, the financial
condition and results of operations of the Company.







Dated:  April
      11, 2008
            /s/ Scott AbsherBy:  Scott
      W. AbsherIts:  President








A signed
original of this written statement required by Section 906 has been provided to
NeoTactix Corporation and will be retained by NeoTactix Corporation and
furnished to the Securities and Exchange Commission or its staff upon
request.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM BALANCE
SHEET STATEMENT OF OPERATIONS AND STATEMENT OF STOCKHOLDER EQUITY (DEFICIENCY)
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH 10K-SB
</LEGEND>
<CURRENCY> U.S. DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          JUN-30-1995
<PERIOD-START>                             JUL-01-1994
<PERIOD-END>                               JUN-30-1995
<EXCHANGE-RATE>                                      1
<CASH>                                          81,341
<SECURITIES>                                         0
<RECEIVABLES>                                   18,786
<ALLOWANCES>                                     1,879
<INVENTORY>                                     18,284
<CURRENT-ASSETS>                               124,224
<PP&E>                                       2,495,613
<DEPRECIATION>                                 268,135
<TOTAL-ASSETS>                               2,752,965
<CURRENT-LIABILITIES>                          340,763
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            98
<OTHER-SE>                                   2,412,104
<TOTAL-LIABILITY-AND-EQUITY>                 2,752,965
<SALES>                                        274,419
<TOTAL-REVENUES>                               274,419
<CGS>                                          237,188
<TOTAL-COSTS>                                  237,188
<OTHER-EXPENSES>                               551,983
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                              (514,752)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (512,757)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (512,757)
<EPS-PRIMARY>                                    (.05)
<EPS-DILUTED>                                    (.05)
        

</TABLE>
**Exhibit 31.2**

**CERTIFICATIONS**

I, Sean P. Washchuk, certify that: 

1.    I have reviewed this Quarterly Report on Form 10-Q of Vitran Corporation Inc.; 

2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material factnecessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, resultsof operations and cash flows of the registrant as of, and for, the periods presented in this report; 

4.    Theregistrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as definedin Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: 

a)    Designed such disclosure controls andprocedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within thoseentities, particularly during the period in which this report is being prepared; 

b)    Designed such internal control overfinancial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements forexternal purposes in accordance with generally accepted accounting principles; 

c)    Evaluated the effectiveness of theregistrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)    Disclosed in this report any change in the registrant’s internal control over financial reporting that occurredduring the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 

5.    The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal controlover financial reporting, to the registrant’s auditors and the Audit Committee of the registrant’s Board of Directors: 

a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reportingwhich are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and 

b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 2, 2011
NUMBER 13-11-00744-CV

COURT OF APPEALS

THIRTEENTH DISTRICT OF TEXAS

CORPUS CHRISTI - EDINBURG

BNP OIL AND GAS PROPERTIES, LTD., Appellant,

v.

TOBY SHOR AND 

SEASHORE INVESTMENTS MANAGEMENT TRUST, Appellees.

On appeal from the County Court at Law No. 3

of Nueces County, Texas.

MEMORANDUM OPINION

Before Chief Justice Valdez and Justices Garza and Benavides

Memorandum Opinion Per Curiam

BNP Oil and Gas Properties, Ltd., perfected an appeal from a judgment entered in 

trial court cause number 09-60343-3 by the County Court at Law No. 3 of Nueces County, 

Texas. This appeal was originally docketed in appellate cause 13-11-00413-CV. In 

that cause, appellant filed a motion to voluntarily dismiss the appeal. By order, the Court 
2

granted the motion and ordered the appeal of BNP Oil and Gas Properties, Ltd. to be 

severed and placed in this cause for disposition. See TEX. R. APP. P. 42.1(a). 

The Court, having considered the documents on file and BNP Oil and Gas 

Properties, Ltd.’s motion to voluntarily dismiss the appeal, is of the opinion that the motion 

should be granted. The motion to dismiss is granted, and the appeal is hereby 

DISMISSED. Costs will be taxed against appellant. See id. R. 42.1(d) ("Absent 

agreement of the parties, the court will tax costs against the appellant."). Having 

dismissed the appeal at appellant’s request, no motion for rehearing will be entertained, 

and our mandate will issue forthwith.

PER CURIAM

Delivered and filed the

1st day of December, 2011.